Raymond's net profit increases by 91.92% in Q3 FY24
Thu, Feb 1, 2024 8:53 PM

Raymond's net profit increases by 91.92% in Q3 FY24

A Flip by Avya Verma
Get it on Google Play
NEW DELHI: Raymond has reported a growth of 91.92 per cent in its net consolidated profit during the quarter ended December 30, 2023. Its profit after tax stood at Rs 185.39 crore in Q3 FY24 as against Rs 96.60 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing.The company's net consolidated total income stood at Rs 2,450.32 crore.

More great flips

Ind-Swift Labs Consolidated September 2024 Net Sales at Rs 11.96 crore

Ind-Swift Labs Consolidated September 2024 Net Sales at Rs 11.96 crore

Reported Consolidated quarterly numbers for Ind-Swift Laboratories are: Net Sales at Rs 11.96 crore in September 2024 down 95.87% from Rs. 289.71 crore in September 2023. Quarterly Net Profit at Rs. 0.41 crore in September 2024 down 98.69% from Rs. 31.66 crore in September 2023. EBITDA stands at Rs. 1.21 crore in September 2024 down 98.34% from Rs. 73.09 crore in September 2023.

Open Flip
Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore

Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore

Reported Consolidated quarterly numbers for Natco Pharma are: Net Sales at Rs 1,371.10 crore in September 2024 up 32.94% from Rs. 1,031.40 crore in September 2023. Quarterly Net Profit at Rs. 677.30 crore in September 2024 up 83.55% from Rs. 369.00 crore in September 2023. EBITDA stands at Rs. 868.10 crore in September 2024 up 78.11% from Rs. 487.40 crore in September 2023.

Open Flip
Marksans Pharma Consolidated September 2024 Net Sales at Rs 641.92 crore

Marksans Pharma Consolidated September 2024 Net Sales at Rs 641.92 crore

Reported Consolidated quarterly numbers for Marksans Pharma are: Net Sales at Rs 641.92 crore in September 2024 up 20.84% from Rs. 531.24 crore in September 2023. Quarterly Net Profit at Rs. 96.72 crore in September 2024 up 15.8% from Rs. 83.52 crore in September 2023. EBITDA stands at Rs. 146.74 crore in September 2024 up 10.38% from Rs. 132.94 crore in September 2023.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon